Nuwellis, Inc.
NUWE- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001506492
No open-market purchases or sales by Nuwellis, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $63.9K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Nuwellis, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 15 | +15 |
| Shares | 0 | 674.8K | +674.8K |
| Value | $0 | $2.83M | +$2.83M |
New holders (15)
Institutions that held Nuwellis, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 224,555 | $943.0K | 0.00% |
| Bard Associates Inc | 173,918 | $730.0K | 0.24% |
| Kepos Capital LP | 83,803 | $352.0K | 0.03% |
| Renaissance Technologies LLC | 54,900 | $231.0K | 0.00% |
| Geode Capital Management, LLC | 37,258 | $156.0K | 0.00% |
| Millennium Management LLC | 26,609 | $112.0K | 0.00% |
| Bank of New York Mellon Corp | 17,980 | $76.0K | 0.00% |
| Advisory Services Network, LLC | 14,500 | $61.0K | 0.00% |
| Searle & Co. | 13,750 | $58.0K | 0.02% |
| Virtu Financial LLC | 13,658 | $57.0K | 0.01% |
| Citadel Advisors LLC | 10,609 | $45.0K | 0.00% |
| UBS Group AG | 1,897 | $8.00K | 0.00% |
| Financial Perspectives, Inc | 1,345 | $5.65K | 0.00% |
| JPMorgan Chase & Co | 2 | $0 | 0.00% |
| Wells Fargo & Company | 42 | $0 | 0.00% |
Sold out (0)
Institutions that held Nuwellis, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
None.